WordNet

provide a fund for the redemption of principal or payment of interest
a reserve of money set aside for some purpose (同)monetary fund
accumulate a fund for the discharge of a recurrent liability; "fund a medical care plan"
convert (short-term floating debt) into long-term debt that bears fixed interest and is represented by bonds
furnish money for; "The government funds basic research in many areas"
invest money in government securities
place or store up in a fund for accumulation
(anatomy) the base of a hollow organ or that part of the organ farthest from its opening; "the uterine fundus"; "the fundus of the stomach"
a yellow dye that is visible even when highly diluted; used as an absorption indicator when silver nitrate solution is added to sodium chloride in order to precipitate silver chloride (turns pink when no chloride ions are left in solution and negative fluorescein ions are then absorbed) (同)fluoresceine, fluorescent_dye, resorcinolphthalein
roentgenographic examination of blood vessels after injection of a radiopaque contrast medium; produces an angiogram
exhibit or undergo fluorescence

PrepTutorEJDIC

(特定の目的のための)『資金』,基金《+『for』+『名』》 / 《a ~》(すぐに役立つ知職などの)『蓄え』,蓄積(stock)《+『of』+『名』》 / 《複数形で》手元資金,所持金;《英》公債,国債 / 〈事業・研究など〉‘に'資金を提供する / 〈負債〉‘を'長期公債にする
けい光を発する

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

1. 乳頭浮腫の概要および鑑別診断 overview and differential diagnosis of papilledema
2. 網膜静脈閉塞：疫学、臨床症状、および診断 retinal vein occlusion epidemiology clinical manifestations and diagnosis
3. 糖尿病性網膜症：分類および臨床的特徴 diabetic retinopathy classification and clinical features
4. 原発性眼障害関連の網膜血管炎 retinal vasculitis associated with primary ocular disorders
5. 糖尿病性網膜症：予防および治療 diabetic retinopathy prevention and treatment

Two novel mutations in the bestrophin-1 gene and associated clinical observations in patients with best vitelliform macular dystrophy.

Lin Y1, Gao H2, Liu Y1, Liang X1, Liu X1, Wang Z1, Zhang W1, Chen J1, Lin Z1, Huang X1, Liu Y1.
Molecular medicine reports.Mol Med Rep.2015 Aug;12(2):2584-8. doi: 10.3892/mmr.2015.3711. Epub 2015 Apr 30.
The purpose of the current study was to investigate the 11 bestrophin-1 (BEST1) exons in patients with best vitelliform macular dystrophy (BVMD), and to characterize the associated clinical features. Complete ophthalmic examinations were conducted on two families, and two family members were diagnos
PMID 25936525

Matson ME1, Ly SV, Monarrez JL.
Optometry and vision science : official publication of the American Academy of Optometry.Optom Vis Sci.2015 Aug;92(8):e180-9. doi: 10.1097/OPX.0000000000000639.
PURPOSE: Best vitelliform macular dystrophy is a hereditary retinal disease characterized by accumulation of lipofuscin in the central macula of both eyes. Lesions typically emerge in the first to second decade and frequently lead to significant visual acuity reduction. The diagnosis is made by the
PMID 26099059

SUBTHRESHOLD MICROPULSE YELLOW LASER VERSUS SUBTHRESHOLD MICROPULSE INFRARED LASER IN CENTER-INVOLVING DIABETIC MACULAR EDEMA: Morphologic and Functional Safety.

Vujosevic S1, Martini F, Longhin E, Convento E, Cavarzeran F, Midena E.
Retina (Philadelphia, Pa.).Retina.2015 Aug;35(8):1594-603. doi: 10.1097/IAE.0000000000000521.
BACKGROUND: To evaluate and compare in vivo retinal and choroidal morphologic changes and macular function in patients treated with yellow (Y-MPL) or infrared (IR-MPL) subthreshold micropulse laser in center-involving diabetic macular edema.METHODS: Prospective, randomized, single institution, compa
PMID 25719988

新井歌奈江/小暮朗子/小野まどか/田村明子/堀貞夫
東京女子医科大学雑誌 82(E1), E254-E259, 2012-01-31
目的:レーザースペックルフローグラフィー(LSFG)による切迫型網膜中心静脈閉塞症の血流動態の観察を行ったので報告する。,症例:30歳の女性。特発性血小板減少紫斑病の診断にてステロイドパルス療法を受けていた。治療4日後から左眼視野に光視症を主訴に当科受診した。視力は良好であったが、左眼網膜静脈は拡張、蛇行し、フルオレセイン蛍光眼底造影(FA)にて腕網膜時間の遅延を認めた。LSFGでは、右眼と比較し …
NAID 110008767987

河原純子,兵藤透,太田昌邦,平良隆保,日台英雄,石井大輔,吉田一成,馬場志郎
日本透析医学会雑誌 = Journal of Japanese Society for Dialysis Therapy 44(8), 695-698, 2011-08-28
蛍光眼底造影剤は，眼科領域では網脈絡膜疾患の診断，治療効果の判定に不可欠な検査である．今回，糖尿病性腎症にて血液透析中の44歳女性に対し眼底出血の疑いのため蛍光造影剤（フルオレサイト®静注500mg，以下一般名フルオレセインと記す）を使用した．造影後に透析を行った際，透析液排液ラインに造影剤の蛍光色が視認できたため，独自に作製したカラースケールを用いて廃液ラインの排液色の変化による造影剤 …
NAID 10029583102